Department of Internal Medicine, Division of Gastroenterology, Center for Aging, University of Texas Medical Branch, Galveston, Texas 55905, USA.
Eur J Gastroenterol Hepatol. 2012 Oct;24(10):1178-84. doi: 10.1097/MEG.0b013e328355cce0.
Hepatitis C virus (HCV) infection and alcohol abuse are common causes of cirrhosis in the USA. There are limited data on HCV prevalence and mortality trends in patients with alcoholic hepatitis (AH).
The present study was carried out to assess HCV prevalence and mortality in AH patients.
Patients with a primary or a secondary discharge diagnosis of AH obtained from the Nationwide Inpatient Sample dataset (1998-2007) were stratified based on the presence of HCV. Factors associated with HCV positivity and in-hospital mortality were examined using multivariable logistic regression.
Of 76 957 719 admissions, 111 726 had AH (7240 were HCV positive). The prevalence of HCV in AH patients was 3.6% in 1998 and 7.7% in 2007. In-hospital mortality was 3.2% (6.3% in 1998 and 2.7% in 2007), with an ~7% annual decrease between 1998 and 2007. HCV was an independent predictor of in-hospital mortality after controlling for calendar year [odds ratio 1.29; 95% CI (1.12-1.49); P=0.0005].
Patients with AH have a higher prevalence of HCV compared with the general population. Although in-hospital mortality in AH patients has improved, HCV infection predicts a higher mortality. Further studies are required to determine the mechanisms of interaction of HCV and AH and develop treatment strategies to improve outcome of HCV-infected AH patients.
在美国,丙型肝炎病毒(HCV)感染和酗酒是导致肝硬化的常见原因。关于酒精性肝炎(AH)患者中 HCV 流行率和死亡率趋势的数据有限。
本研究旨在评估 AH 患者中 HCV 的流行率和死亡率。
从全国住院患者样本数据集(1998-2007 年)中获取原发性或继发性 AH 出院诊断的患者,根据 HCV 的存在进行分层。使用多变量逻辑回归检查与 HCV 阳性和院内死亡率相关的因素。
在 76957719 例住院患者中,有 111726 例患有 AH(7240 例为 HCV 阳性)。1998 年 AH 患者中 HCV 的流行率为 3.6%,2007 年为 7.7%。院内死亡率为 3.2%(1998 年为 6.3%,2007 年为 2.7%),1998 年至 2007 年期间每年下降约 7%。在控制了年份后,HCV 是院内死亡率的独立预测因子[比值比 1.29;95%可信区间(1.12-1.49);P=0.0005]。
与一般人群相比,AH 患者中 HCV 的流行率更高。尽管 AH 患者的院内死亡率有所改善,但 HCV 感染预示着更高的死亡率。需要进一步研究以确定 HCV 和 AH 的相互作用机制,并制定治疗策略以改善 HCV 感染的 AH 患者的预后。